Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Other Accumulated Expenses (2016 - 2025)

Amn Healthcare Services (AMN) has disclosed Other Accumulated Expenses for 16 consecutive years, with $116.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 58.0% year-over-year to $116.8 million, compared with a TTM value of $116.8 million through Dec 2025, up 58.0%, and an annual FY2025 reading of $116.8 million, up 58.0% over the prior year.
  • Other Accumulated Expenses was $116.8 million for Q4 2025 at Amn Healthcare Services, up from $73.9 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $162.4 million in Q4 2021 and bottomed at $15.0 million in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $63.5 million, with a median of $59.6 million recorded in 2022.
  • The sharpest move saw Other Accumulated Expenses soared 1384.91% in 2021, then crashed 80.27% in 2022.
  • Year by year, Other Accumulated Expenses stood at $162.4 million in 2021, then plummeted by 80.27% to $32.0 million in 2022, then plummeted by 53.16% to $15.0 million in 2023, then skyrocketed by 392.44% to $73.9 million in 2024, then surged by 58.0% to $116.8 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for AMN at $116.8 million in Q4 2025, $73.9 million in Q4 2024, and $23.7 million in Q3 2024.